- US Capitol Capsule: Allocating scarce drugs: Quandary beyond Ebola
- US Capitol Capsule: 5 years of Obamacare: debates, glitches & millions insured
- US Capitol Capsule: Drug price 'yellow' signs: market canaries or lemons?
- US Capitol Capsule: Rare disease sector matures; FDA keeping pace?
- The EMA at 20: Guido Rasi looks at how the EU regulatory landscape might change over the next decade
- INTERVIEW: Actavis CEO Saunders staying put as Allergan deal nears close
JOB OF THE WEEK Promote your job vacancy